Tagged With Drug Development

Belgian biotech Galapagos surges after Gilead sinks another $5.1 billion into the firm

A top Novartis executive says the $225 billion drug giant is planning for a 'doomsday scenario' in cancer treatment

The FDA just approved a drug that targets cancers based on DNA, rather than where the tumour is in your body

Here's the email 23andMe sent its customers after GSK bought a $300 million stake in the company

DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here's how to delete your data if that freaks you out.

A biotech company's farthest-along drug just failed a key trial -- and the stock is plummeting

There could be a $35 billion market to treat NASH, a 'silent disease' millions are living with -- and the competition's starting to heat up

The FDA just refused to review a new depression drug -- and the company's stock is tanking

A startup that uses software to discover new drugs just raised $10 million

BANK OF AMERICA: There's one area of the stock market that stands above the rest

Traders were blindsided by Celgene's massive earnings flop

The maker of Botox has turned to the oldest trick in the book to save its cratering stock

A company that wants to use ultrasounds to deliver drugs just raised money from MIT's new $170 million venture fund

23andMe is getting serious about drug development -- and it could signal a fresh approach to finding new medicines

A 32-year-old biotech CEO just raised $1.1 billion from SoftBank to give old drugs new life

There's an eye-popping alternative to overheated tech stocks

The FDA just made a move that could prevent the next drug price gouger

There's a surprising new champion of the stock market

The Trump administration is gearing up to take an official stance on prescription drug prices -- here's what to expect

Pharma CEOs expect Trump to do something about drug pricing in the next 3 months